An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Soluble Film (DBSF) in Pediatric, Adolescent and Adult Subjects With Epilepsy

Trial Profile

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Buccal Soluble Film (DBSF) in Pediatric, Adolescent and Adult Subjects With Epilepsy

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2018

At a glance

  • Drugs Diazepam (Primary)
  • Indications Seizures
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Aquestive Therapeutics
  • Most Recent Events

    • 16 Feb 2018 Status changed from not yet recruiting to recruiting.
    • 30 Nov 2017 According to a Aquestive Therapeutics media release, MonoSol Rx changed its name to Aquestive Therapeutics
    • 07 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top